Merit Medical Reports Third Quarter 2026 Results: Delivers 9% Organic Constant Currency Revenue Growth and Raises Full-Year 2026 Guidance

Financial Highlights† Reported revenue of $416.2 million, up 8.4%Constant currency revenue* and constant currency revenue, organic* up 8% and up...

OSE Immunotherapeutics Reports Additional Positive Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer

Final positive readout for primary and several secondary endpoints presented by Federico Cappuzzo, MD, PhD, on October 25, 2026, at...

FEM By UPSA Highlights Growing Body of Research on Non-Hormonal Menopause Support, Including Studies in Breast Cancer Survivors

Decades of research address key considerations for healthcare professionals discussing non-hormonal menopause options with patientsRUEIL-MALMAISON, France, Oct. 29, 2026 (GLOBE...

error: Content is protected !!